Bon Secours Mercy Health is reported to be in late-stage discussions to buy a majority stake in Surgery Partners, valuing the company at about $20 per share, with talks described as nearing completion. The Financial Times is cited by multiple outlets as the source of the information, including details that the deal is close to about $6 billion.
The reporting also frames Surgery Partners as Bain-backed and highlights that Bon Secours is joining a broader pattern of not-for-profit hospital providers pursuing large transactions in the US healthcare sector. While the different outlets largely restate the same core deal details, their emphasis varies—some focus on the size of the potential acquisition and the valuation per share, while others add context around the not-for-profit nature of the buyer and the role of Bain.
No articles provided here include confirmation of deal terms beyond the reported valuation and share price, nor do they specify expected timing, regulatory steps, or whether the discussions will definitely lead to an agreement.
